# \[e-drug\] Unique adherence challenges to ART

**URL:** <https://talk.edrugplus.org/t/e-drug-unique-adherence-challenges-to-art/26792>\
**Category:** e-drug\
**Created:** [November 17, 2006, 7:33am UTC](https://talk.edrugplus.org/t/e-drug-unique-adherence-challenges-to-art/26792 "2006-11-17T07:33:18Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Noah\_K\_Tarus](https://avatars.discourse-cdn.com/v4/letter/n/53a042/32.png) [@Noah\_K\_Tarus](https://talk.edrugplus.org/u/Noah_K_Tarus)\
**Post date:** [November 17, 2006, 7:33am UTC](https://talk.edrugplus.org/t/e-drug-unique-adherence-challenges-to-art/26792/1 "2006-11-17T07:33:18Z")

</div>

E-DRUG: Unique adherence challenges to ART  
--------------------------------------------

[Please respond directly to Noah. "Noah K. Tarus" \<NTarus@wrp-kch.org\>. Noah please could you collate responses so we can share them on e-drug? Thanks, BS. Moderator]

Dear e-druggers,

Given the critical nature of strict adherence in ART, I am evaluating  
unique adherence challenges to ART in rural Kenya (Kericho area) with  
the aim of presenting plausible interventions.

I welcome any contributions from you.

Thank you,

Noah Tarus  
Pharmacist.  
Walter Reed Project.  
P.o Box 1357-20200  
Kericho, KENYA.  
TEL- 254-52-30686/21064, FAX-254-52-30546.  
CELL-254-52-722462932  
ntarus@wrp-kch.org  
or  
tarusn@yahoo.co.uk